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vert the mitogenic action of IGF-I into a hypertrophic responseExpression of insulin-like growth factor-I and transforming
in these segments. It is also conceivable that TGF-b may be agrowth factor-b in hypokalemic nephropathy in the rat.
cause of the tubulointerstitial infiltrate. Finally, the low circulat-Background. Potassium deficiency (KD) in the rat retards
ing IGF-I levels likely contribute to the impaired body growth.body growth but stimulates renal enlargement caused by cellu-
lar hypertrophy and hyperplasia, which is most marked in the
outer medulla. If hypokalemia persists, interstitial infiltrates
appear and eventually fibrosis. Since early in KD insulin-like Potassium deficiency (KD) has remarkable and oppo-growth factor-I (IGF-I) levels in the kidney are elevated, sug-
site effects on kidney and body growth. When rats aregesting that it may be an early mediator of the exaggerated
placed on a K-deficient diet, renal growth accelerates,renal growth, and as transforming growth factor-b (TGF-b)
promotes cellular hypertrophy and fibrosis, we examined the and within eight days, there is a 25% increase in kidney
renal expression of these growth factors in prolonged KD. mass [1]. In contrast, body growth slows down [1, 2].
Methods. Rats were given a K-deficient diet or were pair The renal enlargement is the result of expansion of allfed or ad libitum fed a K-replete diet for 21 days. Growth factor
the regions of the kidney and occurs through both tubulemRNA levels were measured in whole kidney and protein
cell hypertrophy and hyperplasia. These changes areexpression localized by immunohistochemistry.
Results. KD rats weighed less than pair-fed controls, while most prominent in the outer medulla, especially the inner
the kidneys were 49% larger. Their serum IGF-I and kidney stripe [3, 4]. In this region of the kidney, the hyperplastic
IGF-I protein levels were depressed, as were their IGF-I mRNA enlarged collecting duct (CD) cells form cellular out-levels in liver, kidney, and muscle. These changes can largely
growths that project into the lumen causing partial ob-be attributed to decreased food intake. In contrast, kidney IGF
struction. In contrast to the increase in size of the renalbinding protein-1 (IGFBP-1) mRNA and TGF-b mRNA levels
were increased significantly. Histology of outer medulla revealed tubules, glomerular volume remains essentially unchanged
marked hypertrophy and adenomatous hyperplasia of the col- [4]. If the K-deficient state persists, then cellular infil-
lecting ducts and hypertrophy of the thick ascending limbs of trates appear in the renal interstitial compartment, and
Henle with cellular infiltrates in the interstitium. Both nephron
eventually, tubulointerstitial fibrosis develops [5]. In hu-segments immunostained strongly for IGF-I and IGFBP-1, but
mans with long-standing KD, there is a propensity toonly the nonhyperplastic enlarged thick ascending Henle limb
form renal cysts and to develop tubulointerstitial fibrosiscells immunostained for TGF-b, which was strongly positive.
Prominent interstitial infiltrates with ED1 immunostained mono- with loss of renal function [6, 7].
cytes/macrophages were present. Studies from this and other laboratories have identi-
Conclusions. These findings are consistent with a sustained fied insulin-like growth factor-I (IGF-I) as a potentialrole for IGF-I in promoting the exaggerated renal growth of
mediator of the early renal hypertrophy [1, 8, 9]. Indeed,KD and appear to be mediated through local trapping of IGF-I
kidney IGF-I levels are elevated even before the kidneysby the overexpressed IGFBP-1, which together with IGF-I can
promote renal growth. The selective localization of TGF-b to enlarge [9]. The increase in IGF-I occurs despite low kid-
hypertrophied nonhyperplastic nephron segments containing ney IGF-I mRNA and serum IGF-I protein levels and
IGF-I raises the possibility that TGF-b may be serving to con- has been attributed to local trapping of IGF-I by IGF
binding protein-1 (IGFBP-1), a member of a family of
IGF binding proteins [10]. In KD animals, IGFBP-1 isKey words: potassium deficiency, cathepsin, kidney disease, fibrosis,
renal growth, hypertrophy. produced in increased amounts in the kidney [1, 8], and
after seven days of KD, there is immunohistochemicalReceived for publication December 21, 1999
evidence of an increase in both IGFBP-1 and IGF-I in theand in revised form June 8, 2000
Accepted for publication July 27, 2000 hyperplastic distal nephron segments [8]. Paradoxically
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also been implicated in the impaired body growth. It has imager (Molecular Dynamics, Sunnyvale, CA, USA).
The abundance of each mRNA was adjusted for thebeen suggested that diminished GH secretion, low serum
and tissue IGF-I levels, and resistance to GH and IGF-I levels of the 18S rRNA readings obtained from photo-
graphic negatives of the nitrocellulose filters.may all contribute to the growth retardation [1, 2].
In this study, we set out to examine the role of the renal The GH receptor probe was prepared from the 2.2 kb
full-length mouse cDNA (Dr. F. Talamantes, UniversityGH/IGF-I axis in the progressive renal enlargement and
tubulointerstitial disease of chronic KD. In addition, of California, Santa Cruz, CA, USA). This cDNA en-
codes the extra (GH receptor binding protein) throughsince transforming growth factor-b (TGF-b) has been
identified as a major mediator of tubular cell hypertrophy intracellular domain of the receptor [14]. The cDNA
probe for IGFBP-1 was prepared from rat cDNA (Dr.and interstitial fibrosis [11, 12], we also examined the
expression of this growth factor to see whether it might S. Shimasaki, Whittier Institute, La Jolla, CA, USA),
which consisted of 407 bp corresponding to the codingbe playing a role in hypokalemic nephropathy. In the
anatomical component of this study, we focused on the region spanning nucleotide position 486 to 892 in the rat
IGFBP-1 cDNA sequence [15]. The cDNA probe forouter renal medulla since the morphologic changes are
most severe in this region of the kidney [3, 4]. TGF-b was prepared from mouse cDNA (Dr. D.E.
Miller, University of Utah School of Medicine, Salt Lake
City, UT, USA) The probe corresponded to the coding
METHODS
region from amino acid 298 to 390 in the mouse TGF-b
Animal and experimental design protein sequence. The cathepsin B probe consisted of
1200 bp of the mouse cDNA coding region (Dr. A. Frank-Male Sprague-Dawley rats weighing approximately
170 g were placed on a 1% K diet, and after a run-in fater, Loyola University, Chicago, IL, USA) [16]. The
cathepsin L probe consisted of 1162 bp of the mouseperiod of five days, they were separated into three groups
comprising six rats per group. Group 1 consisted of cDNA coding region (Dr. G. Gary Sahagian, Tufts Uni-
versity, Boston, MA, USA) [17]. The cDNA probes wereK-deficient rats fed on an ad libitum 0.01% K diet. This
diet was otherwise identical to the 1% diet (Purina, Rich- labeled with 50 mCi [32P]-dCTP by a random primer
method (Multiprime DNA labeling system; Amershammond, IN, USA). Group 2 consisted of rats kept on a
1% K diet and pair fed with the group 1 rats. Group 3 Biotech, Piscataway, NJ, USA). Radiolabeled probes
were purified through a G-50 Sephadex column.consisted of control rats maintained on an ad libitum
1% K diet. During the study, rats were weighed daily,
Solution hybridization/RNAse protection assayand their food consumption was measured. After 21 days
of study, the rats were sacrificed. The kidneys, liver, and These assays were performed exactly as before [13].
In short, total RNA (20 mg) was hybridized with a-32P-muscle were removed and weighed. One kidney and
the other tissues were frozen in liquid nitrogen. The CTP labeled antisense IGF-I or IGF-I receptor and 18S
rRNA probes overnight. The mixture was then incubatedremaining kidney was bisected, fixed in 4% paraformal-
dehyde, and paraffin embedded. with an RNAse digestion buffer followed by the addition
of proteinase K. Ethanol-precipitated protected hybrids
Northern blot analysis were separated on a 5% polyacrylamide/8 mol/L urea
denaturing gel. Autoradiographs or phosphorimages wereTotal kidney RNA was isolated by an acid guanidi-
nium thiocyanate-phenol chloroform single-step method obtained, and the density of the protected bands was
measured. Only the Ea IGF-I mRNA transcripts wereand was size separated by agarose gel electrophoresis as
before [13]. In short, 20 mg of total RNA were separated quantitated since it accounted for .95% of the IGF-I
mRNA signal in the kidney and muscle. The IGF-I ribo-by electrophoresis through a denaturing agarose gel con-
taining 0.55 mol/L formaldehyde. RNA was transferred probe, a 376 bp Sau3 A-EcoRI fragment, was designed
to detect both the Ea and Eb IGF-I mRNAs [18]. Theto nitrocellulose filters and photographed under ultravio-
let light. Filters were then prehybridized in a solution IGF-I receptor riboprobe contained 280 bases comple-
mentary to the IGF-I receptor mRNA. The 18S ribo-containing 50% formamide, 1.5 3 SSPE, 2.5 3 Denhart’s
solution, 50 mg/mL salmon sperm DNA, 0.2% sodium probe contained 80 complementary bases of the human
18S rRNA [19].dodecyl sulfate (SDS) at 428C for four hours. The mRNA
levels of the GH receptor, IGFBP-1, TGF-b, and cathep-
Kidney plasma membrane IGF-I receptorsins B and L were detected by hybridizing radiolabeled
binding assaycDNA probes to the mRNA at 428C overnight. Washed
filters were then exposed to x-ray films, and the mRNA Crude plasma membranes were isolated from the kid-
ney as before [13]. The kidney was homogenized in 8%was quantitated by laser densitometry (GelscanXL; Phar-
macia LKB, Alameda, CA, USA). Alternatively, the fil- buffered sucrose, pH 7.0, followed by differential centri-
fugation and collection of a 47,000 3 g pellet in calcium-ters were exposed and the signals measured in a phosphor-
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free Krebs-Ringer HEPES buffer (KRH; pH 7.4). Mem- lead thiocyanate and 1% zinc sulfate in distilled water,
as described by Shi, Key, and Kalra [20]. After washingbrane receptor binding was determined as before with mi-
nor modifications [13]. In brief, 100 mg of membrane pro- in phosphate-buffered saline (PBS) containing Tween-
20, sections were incubated with 10% normal goat serumtein were incubated at 48C overnight with 10 to 11 mol/L
125I-IGF-I in a binding buffer consisting of 150 mmol/L in 0.1 mol/L Tris with 0.05% Tween-20 at room tempera-
ture for 30 minutes to suppress nonspecific binding. Sec-NaCl, 50 mmol/L HEPES, pH 7.4, with 0.1% bovine se-
rum albumin (BSA), 2 mmol/L bacitracin, and 5 mmol/L tions were briefly rinsed with PBS with Tween-20, and
the specific primary antibody was applied for two hoursN-ethylmaleimide. Free and membrane-bound 125I-IGF-I
were separated by centrifugation. The pellet was washed, at room temperature. To demonstrate specificity of bind-
ing, a second set of sections was incubated with an equaland the radioactivity was counted. Nonspecific 125I-IGF-I
binding was measured by displacement with 1026 mol/L of concentration of normal rabbit serum or nonimmune
mouse IgG diluted in 0.1 mol/L Tris with Tween-20 in-unlabeled IGF-I, a gift from Genentech Inc. (South San
Francisco, CA, USA). IGF-I was radiolabeled with 125I-Na stead of specific primary antibody. Sections were rinsed
in PBS with Tween-20 and a secondary antibody (biotin-by the chloramine-T method [13].
ylated goat anti-rabbit or anti-mouse IgG; Vector Labo-
Radioimmunoassay of serum and kidney IGF-I peptide ratories, Burlingame, CA, USA) was applied for 30 min-
utes. Sections were washed in PBS for 20 minutes andInsulin-like growth factor-I was measured by radioim-
munoassay (RIA) in acid-ethanol extracts of serum and incubated with streptavidin-horseradish peroxidase (Vec-
tor Laboratories) for 30 minutes. After a rinse and washacetic acid extracts of kidney with a commercial RIA kit
(Nichols Institute, San Juan Capistrano, CA, USA) as be- in PBS with Tween-20 for 20 minutes, diaminobenzidine
(Sigma Chemical, St. Louis, MO, USA) was applied forfore [13]. Recovery of IGF-I added to homogenate of kid-
neys from ad libitum control and K-depleted rats averaged three minutes. Sections were washed in distilled water
and were counterstained with hematoxylin. Coverslips78 6 1.2 and 81 6 1.8%, respectively. Recovery from
serum averaged 96 6 23.9 and 95 6 3.4%, respectively. were applied after dehydration with ethanol and clearing
in xylene.Adjustment for serum IGF-I contamination of kidney sam-
ples was not made because serum trapped in kidney forms
Biochemical measurementsless than 2% of the organ volume, and it has been estimated
that the IGF-I in serum accounts for approximately 6% Serum K was determined in a IL943 flame photometer
(Instrumentation Labs, Lexington, VA, USA) and tissueof kidney tissue IGF-I content [1].
protein by the BioRad method (BioRad Laboratories,
Immunohistochemistry Richmond, CA, USA).
Insulin-like growth factor-I was detected with a rabbit
Data analysispolyclonal anti-human antibody (Drs. L.E. Underwood
and J.J. Van Wyk, National Hormone and Pituitary Pro- Autoradiographic and phosphorimager readings of the
mRNAs of interest were adjusted for the correspondinggram, Bethesda, MD, USA), IGFBP-1 with a rabbit poly-
clonal anti-human antibody (Upstate Biotechnology, Lake 18S rRNA reading. Corrected values are expressed relative
to the average of the control group. For comparison be-Placid, NY, USA), TGF-b1 with a rabbit polyclonal anti-
human antibody selectively directed against TGF-b1 tween the three study groups, the data were analyzed with
an analysis of variance followed by Student–Newman–(Santa Cruz Biotechnology, Santa Cruz, CA, USA) and
ED1 with a mouse anti-rat ED1 monoclonal antibody Keuls t test. A P value of ,0.05 was taken as significant.
Results are expressed as mean 6 SEM and are from five(Serotec Ltd., Oxford, UK). Tamm-Horsfall protein was
detected with a mouse antihuman monoclonal antibody to six rats per group.
(Accurate Chemical & Scientific Corp., Westbury, NY,
USA) and aquaporin 2 with a rabbit polyclonal antibody
RESULTS
provided by Dr. Alan Verkmman (University of Califor-
Serum potassium levels, body and kidney weights, andnia, CA, USA). Anti–IGF-I and IGFBP-1 antibodies were
food conversion efficiencyused in a 1:400 dilution, anti–TGF-b antibody in a 1:50
dilution and the anti-ED1 antibody in a 1:100 dilution. The data from the three groups of animals studied are
given in Table 1. At the end of the 21-day study period,Paraffin-embedded tissue was cut in 4 mm sections and
dewaxed with xylene and hydrated with ethanol in de- serum K level (2.0 6 0.26 mEq/dL) and body weight
were all significantly lower in the K-restricted rats com-creasing concentrations. Sections were then incubated
in 3% hydrogen peroxide for five minutes to quench pared with either the pair-fed or ad libitum fed controls
on a 1% K-replete diet (P , 0.05). Food intake fell whenendogenous peroxidase activity and rinsed in distilled
water. To retrieve antigens, the sections were heated in the rats were placed on the 0.01% K diet and averaged
13 g/day. This was considerably lower than the averagea microwave in the presence of a solution of saturated
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Table 1. Serum body and kidney weight/body weight, food intake and food conversion efficiency
Body weight g
Serum K Kidney weight g Kidney weight/ Cumulative Food conversion
Group N mEq/L Day 0 Day 21 Day 21 body weight % food intake g efficiency %
Ad libitum control 6 4.360.17 16863.1 31064.7 1.0660.04 0.3460.02 38067.1 38.061.0
Pair-fed control 6 3.760.13 17262.4 25067.9a 0.8160.0a 0.3260.01 272610.6a 27.660.8a
Low K 6 2.060.26ab 17163.3 19863.9ab 1.2160.05ab 0.6160.03ab 269612.2a 10.261.0ab
Ad libitum and pair-fed control rats were fed a 1% K diet. Low K rats were fed a 0.01% K diet. Food conversion efficiency 5 body weight gain divided by food
intake 3 100.
a P , 0.05 vs. ad libitum control
b P , 0.05 vs. pair-fed control
Table 2. Relative insulin-like growth factor (IGF-I), IGF-I receptor and growth hormone (GH) receptor mRNA levels in kidney,
muscle and liver
IGF-I IGF-I receptor GH receptor
Tissue Ad libitum Pair-fed Low K Ad libitum Pair-fed Low K Ad libitum Pair-fed Low K
Kidney 100618 4766.9a 4967.6a 100625 176626 17169 100615 79610 6163a
Muscle 10065 8067.2 5567.5ab 10066 10268 10369 10066 8866 7168a
Liver 10068 6266.1a 4663.4a ND ND ND 10069 6968a 6365a
IGF-I and IGF-I R mRNA levels were determined simultaneously in a solution hybridization ribonuclease protection assay. These values were corrected for 18S
rRNA levels measured in the same assays. Corrected values are expressed relative to the average value of the control group, assigned a value of 100. Results are
mean 6 SEM, 5 to 6 rats/group. ND is not detectable.
a P , 0.05 vs. ad libitum control
b P , 0.05 vs. pair-fed control
intake of 18 g/day by the ad libitum fed control rats.
Food conversion efficiency in the K-depleted rats was
one third that observed in the pair-fed controls (10.2 6
1.0 vs. 27.6 6 0.8%, P . 0.01). Thus, despite the equal
quantity of food ingested, the K-deficient rats gained sig-
nificantly less weight than the pair-fed controls over the
three-week period (27 6 2.3 vs. 78 6 6.2 g, P . 0.01).
The largest weight gain occurred in the ad libitum fed
controls (142 6 6 g). In contrast to the lower body weight,
left kidney weight was 49% greater in K-depleted rats
Fig. 1. Relative insulin-like growth factor-I (IGF-I) and IGF-I receptor
than in the pair-fed controls (1.21 6 0.05 vs. 0.81 6 0.01 (IGF-IR) mRNA levels in kidneys of ad libitum fed controls, pair-fed
controls, and K-deficient rats. IGF-I and IGF-IR mRNA levels wereg, respectively, P , 0.01) and 14% greater than in the ad
determined simultaneously in a solution hybridization ribonuclease pro-libitum controls (1.06 6 0.04 g, P , 0.05). When kidney
tection. These values were corrected for the 18S rRNA levels measured
weight was expressed as a percentage of body weight, in the same assays. Corrected values are expressed relative to the
average value of the control group, assigned a value of 100. Representa-the differences between the K-deficient rats and controls
tive autoradiograms are shown. Results are mean 6 SEM, 5 rats/group.were even more striking for the value in the K-deficient
**P , 0.01
group was twofold that of the controls (Table 1).
Insulin-like growth factor-I mRNA levels
lower in the K-deficient group, they did not differ signifi-
These results are summarized in Table 2 and are illus- cantly from the pair-fed control values. In muscle, the
trated in Figure 1. In the K-deficient state, there was IGF-I mRNA levels were reduced by 45% in the
a 51% decrease in kidney IGF-I mRNA levels when K-deficient rats (P , 0.05) and by 20% in the pair fed
compared with the ad libitum control values (P , 0.05). rats (P 5 NS) compared with the ad libitum fed controls.
However, there was a similar 53% decrease in the IGF-I The levels in K-deficient and pair-fed groups differed
mRNA level in the pair-fed control rats, indicating that significantly, indicating that KD has a direct effect on
the fall in IGF-I gene expression can be attributed to IGF-I gene expression in muscle.
attenuated food intake. In liver, the IGF-I mRNA levels
Insulin-like growth factor-I receptor mRNA levelswere reduced by 54% in the K-deficient rats and by 38%
in the pair-fed rats compared with the ad libitum fed These results are summarized in Table 2 and are illus-
trated in Figure 1. Kidney IGF-I receptor mRNA levelscontrols (P , 0.05). Although the levels were on average
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Table 3. Immunoreactive IGF-I concentrations in serum and kidney
Serum Kidney
Group N ng/mL ng/g tissue
Ad libitum 5/6 12836112 537616
Pair-fed 6 855668a 442642
Low K 6 570 671ab 342624ab
a P , 0.05 vs. ad libitum control
b P , 0.05 vs. pair-fed control
Fig. 2. Autoradiogram of Northern blots detecting the mRNA levels
fed controls (119 6 13 arbitrary units), which in turn didof (A) growth hormone receptor (GHR), (B) insulin-like growth factor
binding protein-1 (IGFBP-1), and (C ) transforming growth factor-b not differ from the ad libitum controls. IGFBP-1 mRNA
(TGF-b) in kidneys of ad libitum fed, pair-fed, and K-deficient rats. was not detected in muscle.
Total RNA was separated by electrophoresis through a denaturing
agarose gel containing 0.55 mol/L formaldehyde, transferred to nitrocel-
Transforming growth factor-b mRNA levelslulose filters, and probed with the radiolabeled cDNA. To control for
differences in loading and transfer, the 18S rRNA signal was obtained As shown in Figure 2, kidney TGF-b mRNA levels
from negatives of photographs of the ethidium bromide-stained nitro-
were similar in the pair-fed and ad libitum fed controlcellulose filters taken under ultraviolet light before probing. The mRNA
values were then corrected for the measured 18S rRNA signal. groups (104 6 5 vs. 100 6 5 arbitrary units, respectively).
In contrast, there was a significant 68% increase in the
K-deficient group (168 6 12 arbitrary units, P , 0.05).
were elevated near twofold in both the K-deficient and Cathepsin B and cathepsin L mRNA levels
pair-fed rats compared with the ad libitum controls (P .
In another state of renal hypertrophy associated with0.05). This suggests that the increase in kidney IGF-I
increased renal ammoniagenesis, namely acidosis, wereceptor mRNA levels is mainly due to the reduced food
have shown that the increase in cell protein mass is causedintake. In muscle, the IGF-I receptor mRNA levels were
in part by depressed cathepsin B and cathepsin L genesimilar in the three groups.
expression and activity [21, 22]. Accordingly, we mea-
sured cathepsin B and cathepsin L mRNA levels in theGrowth hormone receptor mRNA levels
present study. An entirely different response occurredAs shown in Table 2 and Figure 2, kidney GH receptor
in the K-deficient state. Depletion of K was associatedmRNA levels were reduced by 44% in the K-deficient
with a threefold increase in kidney cathepsin L mRNArats compared with the ad libitum fed controls (P , 0.05).
levels compared with pair-fed and ad libitum control ratsThe pair-fed control values were modestly reduced, but
(305 6 14 vs. 112 6 9 and 100 6 6 arbitrary units,did not differ from the other groups. A similar response
respectively, P , 0.01). In contrast, cathepsin B mRNAwas seen in liver and muscle. Thus, in all three tissues,
levels did not differ (data not shown) among the threethe fall in GH receptor expression appears to be largely
groups.a direct consequence of KD and in part due to the re-
duced food intake.
IGF-I peptide levels in serum and tissues
IGFBP-1 mRNA levels These results are summarized in Table 3. The serum
IGF-I levels were reduced significantly in the K-deficientThe IGFBP-1 mRNA levels in kidneys from ad libitum
and pair-fed groups (P , 0.05) compared with the adand pair-fed controls and the K-deficient rats are de-
libitum controls. The lowest values were seen in thepicted in Figure 2. While the IGFBP-1 mRNA levels in
K-deficient group (P , 0.05) and indicate that the lowthe pair-fed and ad libitum-fed control groups did not
serum IGF-I levels in KD can only partly be explaineddiffer significantly, the values in the K-deficient group
by the reduced food intake. The IGF-I levels in the wholewere significantly higher than in both the control groups
kidney were significantly lower in the K-deficient group(P , 0.05). Indeed, the average IGFBP-1 mRNA level
compared with the ad libitum controls (342 6 24 vs. 537 6in the K-deficient group was 11-fold greater than in the
16 ng/g), while the levels in the pair-fed rat kidneysad libitum controls (1085 6 115 vs. 100 6 14 arbitrary
were intermediate (442 6 42 ng/g) and did not differunits). In liver, there was only a modest increase in
significantly from the other groups. Since the IGF-IIGFBP-1 mRNA levels in the K-deficient rats compared
mRNA levels in the K-deficient and pair-fed kidneyswith the ad libitum controls (150 6 12 vs. 100 6 10
were depressed to a similar extent and as kidney IGF-Iarbitrary units, P , 0.05). This increase appears to be
peptide is in part serum derived, it is likely that thepartly by the reduced food intake, since the levels in the
K-deficient state did not differ significantly from the pair- lower IGF-I peptide levels in the K-deficient rat kidneys
Tsao et al: Hypokalemic nephropathy 101
compared with the pair-fed rat kidneys reflect the lower DISCUSSION
serum IGF-I levels. In this study, we have evaluated the role of the renal
IGF-I axis and of TGF-b in the renal hypertrophy and
Kidney plasma membrane IGF-I receptor binding tubulointerstitial disease of sustained KD. After three
Specific binding of radiolabeled IGF-I to isolated kid- weeks on a K-depleted diet, food intake decreased, and
ney plasma membranes was increased to a similar extent weight gain was severely attenuated. The latter was in
in the K-deficient and pair-fed groups compared with ad part due to diminished food utilization for the hypoka-
libitum fed group. The values were 14.0 6 1.0, 13.1 6 0.6, lemic rats gained less weight than their pair-fed controls.
and 9.7 6 0.3%/100 mg/membrane protein, respectively In contrast to the lack of body growth, the kidneys en-
(P , 0.05). The increase in binding likely reflects recep- larged and, at the end of the 21-day study, were 49%
tor up-regulation in response to reduced food intake [18]. heavier than the kidneys of pair-fed controls. This in-
crease is double that which we previously observed after
Immunohistochemistry eight days of KD [1]. Thus, in KD, the exaggerated renal
As previously reported by others, there was marked growth continues for a prolonged period of time. The
hypertrophy and adenomatous hyperplasia of the collect- anatomical changes observed are of particular interest
ing ducts (CD) cells in the outer medulla, especially in and were most striking in the outer medulla, especially
the inner stripe [3, 4]. Several of the larger nephron the inner stripe. Tubular epithelial cells were enlarged,
segments had a microcystic appearance. Cellular intersti- and there was exuberant proliferation of some medullary
tial infiltrates were also present with widening of the CD cells with the formation of papillary outgrowths that
interstitium [5]. All of these changes are evident in Figure projected into the dilated tubular lumina, findings consis-
3, which depicts the inner stripe of the outer medulla tent with earlier reports [3, 4]. The enlarged medullary
from pair-fed control (A) and K-deficient (B) animals. CD had a microcystic appearance, and these changes in
The CDs and thick ascending limbs of Henle (TALHs) the rat kidney may serve as a model for the cysts that
of all of the animals displayed IGF-I immunoreactivity, develop in chronically hypokalemic patients [6]. Intersti-
which appears to be increased in the K-deficient kidney tial infiltrates were also present in the KD rat kidneys and
(Fig. 3 A, B). It is noteworthy that in the K-deficient contained ED1-positive cells consistent with monocytes/
animals, both the hyperplastic- and nonhyperplastic- macrophages.
enlarged nephron segments were positively stained. A Serum and kidney IGF-I peptide levels were reduced
similar pattern of immunoreactivity was detected with significantly in the KD rats compared with the ad libitum-
the IGF-BP-1 antibody in the K-deficient animals (Fig. and pair-fed controls, while values in the pair-fed group
3 C, D); both the hyperplastic and nonhyperplastic distal were intermediate. These changes in IGF-I peptide levels
nephron segments showed increased immunostaining. could be attributed to depressed IGF-I gene expression.
TGF-b imunoreactivity was only faintly positive over the IGF-I mRNA levels were reduced in kidney, liver, and
distal nephron segments in control kidneys (Fig. 3E). In muscle, and this appears to be largely, although not en-
contrast, the kidneys of the K-deficient animals displayed tirely, caused by decreased food intake. The observation
strong immunoreactivity over the hypertrophied nonhy- that whole kidney IGF-I peptide levels are low after
perplastic distal nephron segments, while the hyperplas- three weeks of K restriction differs from the situation
tic tubules were devoid of immunoreactivity (Fig. 3F). in early KD [1, 8, 9]. After eight days of K restriction,
This difference in the distribution of TGF-b immunore- kidney IGF-I peptide levels increase more than twofold,
activity compared with that of IGF-I and IGFBP-1 is even though the IGF-I mRNA levels are depressed [1].
particularly noteworthy. Interstitial infiltrates were ab- This paradoxical elevation in kidney IGF-I levels ap-
sent in the control kidneys, while infiltrates present in the pears to be a result of several processes, including in-
K-deficient kidneys displayed ED-1 immunoreactivity creased delivery of IGF-I bound to low-molecular-
consistent with infiltrating macrophages/monocytes (Fig. weight IGFBPs to the kidney, diminished renal IGF-I
3 G, H). To identify the enlarged medullary nephron degradation and trapping by IGFBP-I, which is overex-
segments, sections were immunostained with an anti- pressed in the kidney of K-deficient rats [1, 8, 9]. In the
body against aquaporin-2, which is expressed in the CD, present study, we attribute the low whole kidney IGF-I
or an antibody against Tamm-Horsfall protein, which is peptide levels, present despite an increase in kidney
expressed in the TALH. As depicted in Figure 4A, the IGFBP-1 expression, to the sustained depression of
hyperplastic tubules immunostained for aquaporin-2, IGF-I production. GH receptor mRNA levels were re-
and the hypertrophic nonhyperplastic tubules immuno- duced significantly in kidney, liver, and muscle of the
stained for Tamm-Horsfall protein (Fig. 4B). This pat- KD animals compared with ad libitum fed controls and,
tern of immunostaining identifies these nephron seg- while lower than in the pair-fed controls, were not sig-
nificantly different. The reduction in GH receptor genements as being the CD and TALH, respectively.

Tsao et al: Hypokalemic nephropathy 103
Fig. 4. (A) Aquaporin-2 immunoreactivity in outer stripe of medulla of a K-deficient (KD) rat kidney. Hyperplastic tubules immunostain for
aquaporin-2. (B) Tamm-Horsfall protein immunoreactivity in KD rat kidney. Enlarged nonhyperplastic tubules immunostain for Tamm-Horsfall
protein.
expression, which is coexpressed with IGF-I in the growth in Snell dwarf mice [22]. After five days of IGFBP
treatment, kidney weight increased approximately 50%,TALH the major site of IGF-I gene expression, may
partly account for the reduced whole kidney IGF-I ex- and when given together with IGF-I, the weight in-
creased even more, by approximately 70%. Another pos-pression. Reduced growth hormone receptor gene ex-
pression is consistent with the report that hepatic GH sible explanation for the local increase in IGF-I is selec-
tive up-regulation of IGF-I gene expression in thesereceptor binding is depressed in KD rats [21].
Initially, these findings imply that IGF-I does not play nephron segments, but reduced expression in others.
However, since the TALH is the major site of IGF-Ia role in the progressive renal enlargement of KD. How-
ever, review of the immunohistochemical findings leads gene expression, the fall in whole kidney IGF-I gene
expression likely reflects a corresponding change in ex-us to a different conclusion. In the inner stripe of the
outer medulla, where kidney growth is most exaggerated, pression in this nephron segment [10]. Since the morpho-
logic findings are consistent with that observed after athere was strong staining for IGFBP-1 and IGF-I, which
colocalized over the CD and TALH. Cells of the latter week of KD [8], it suggests that IGF-I may play a continu-
ous role in mediating the exaggerated renal growthnephron segment were enlarged, while those of the CD
were both enlarged and hyperplastic. Since the whole caused by KD. It is also conceivable that IGF-I may play
a role in the expansion of the interstitial infiltrates bykidney IGF-I peptide levels were depressed, these obser-
vations suggest that IGF-I is being sequestered in these stimulating macrophage proliferation [23].
Of particular interest are the changes in TGF-b ex-nephron segments by locally overexpressed IGFBP-1. It
may well be that this trapped IGF-I, possibly together pression in the kidney of the K-restricted rats. Whole
kidney TGF-b mRNA levels were increased, and immu-with the binding protein, serves to stimulate the cellular
proliferation and hypertrophy. Indeed, Van Buul-Offers nohistochemical staining for TGF-b was greatly en-
hanced after three weeks of KD. In the inner stripe ofet al recently reported that infusions of IGFBP-1 alone
or together with IGF-I stimulate kidney, but not body, the outer medulla of the kidneys of normokalemic con-
b
Fig. 3. Localization of IGF-I, IGFBP-1, TGF-b, and ED1 immunoreactivity in the inner stripe of outer medulla of kidneys of hypokalemic rats
on a K-deficient diet for 21 days (B, D, F, and H) and their pair-fed controls (A, C, E, and G). Magnification 3250. Counterstain hematoxylin.
(A) Control kidney, IGF-I immunoreactivity. Note the light immunoperoxidase staining of tubules. (B) K-deficient, IGF-I immunoreactivity. Note
the marked hyperplasia of some tubules, identified as collecting ducts (CDs) in Fig. 4A, with formation of papillary projections (*). Other tubules,
identified as thick ascending limb of Henle (TALH) in Fig. 4B, are enlarged but are not hyperplastic (arrows). Both the hyperplastic and
nonhyperplastic tubules show increased IGF-I immunoreactivity. Prominent interstitial infiltrates are present. (C) Control kidney, IGFBP-1
immunoreactivity. Tubules are lightly immunostained. (D) K-deficient animals, IGFBP-1 immunoreactivity. Immunostaining for IGFBP-1 is intense
and has the same anatomical distribution as IGF-I. Some of the enlarged tubules have an early microcystic appearance. (E) Control kidney,
TGF-b1 immunoreactivity. Tubules are lightly immunostained. (F) K-deficient animal, TGF-b1 immunoreactivity. TGF-b1 immunostaining is
intense and confined to the nonhyperplastic nephron segments. (G) Control kidney, ED-1 immunoreactivity. No immunostaining is evident. (H)
K-deficient animal, ED-1 immunoreactivity. ED1-positive cells (monocytes/macrophages) are present in the interstitial infiltrate.
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trol rats, TGF-b immunostaining was very faint, while sistent with a sustained role for IGF-I in promoting the
in the KD rats, staining was prominent over some, but marked tubular epithelial cell hypertrophy and hyperpla-
not all, of the distal nephron segments. The hypertro- sia that occurs in the inner stripe of the outer medulla
phied TALH were strongly TGF-b positive, while in of the kidney in chronic KD. Furthermore, this appears
contrast, the hyperplastic CD were TGF-b negative. This to be mediated through trapping of IGF-I by local
differs from the distribution of IGF-I and IGFBP-1, as IGFBP-1, which is overexpressed in KD in the ascending
described previously in this article, and leads us to sug- TALH and in the CD. This concept is supported by
gest for consideration that it is the absence of TGF-b in the recent finding that infusions of IGFBP-1 alone or
the CD that allows IGF-I and presumably other growth together with IGF-I stimulate renal growth. We have
factors to stimulate cellular proliferation. In contrast, we also shown that KD causes an increase in the expression
suggest that the presence of TGF-b in the hypertrophied of TGF-b in the kidney. In the outer medulla, it is note-
TALH may serve to convert the mitogenic stimulus of worthy that the TGF-b protein is selectively increased
IGF-I into a hypertrophic response. This is consistent in the hypertrophied nonhyperplastic TALH and, unlike
with the kidney cell culture finding that TGF-b blocked IGF-I, is absent from the hyperplastic CD cells. This
the mitogenic action of insulin and together with insulin distribution raises the possibility that the absence of
induced cellular hypertrophy [24]. We also suggest that TGF-b in the CD allows IGF-I and presumably other
TGF-b may be playing a role in the formation of the growth factors to stimulate cellular proliferation. In con-
prominent interstitial infiltrate in the KD state, since trast, we suggest that the presence of TGF-b in the en-
TGF-b also functions as a chemoattractant for mono- larged nonhyperplastic nephron segments serves to con-
cytes and macrophages from the circulation [25]. vert the mitogenic stimulus of IGF-I into a hypertrophic
It has been proposed that some of the pathologic stimulus. We also propose that TGF-b may also play a
changes in the kidney of KD animals may be initiated role in causing the prominent interstitial infiltrate that
by the high levels of ammonia generated in KD and develops in chronic hypokalemia.
mediated through the activation of the alternate comple-
ment pathway [5]. In support of this thesis is the finding ACKNOWLEDGMENTS
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